Learning Hub Central
Lymphoma

2022 NOSCM | Waldenstrom’s Macroglobulinemia
Lymphoma
Non-CME Credit Course

Updates in Treatment of Lymphoma
Lymphoma
Non-CME Credit Course

2021 AIO | Optimal Therapeutic Strategies for non-Hodgkin lymphoma
Lymphoma
Non-CME Credit Course

2021 UCT | Update from ASCO/AACR/ESMO in T-cell NHL
Lymphoma
Non-CME Credit Course

T-Cell NHL: What’s New?
Lymphoma
Non-CME Credit Course

2021 NOSCM | Follicular Lymphoma: Novel Advances and Pathways
Lymphoma
Non-CME Credit Course

2022 AIO | Lymphoma Data Science from Populations to Precision Medicine and Back
Lymphoma
Non-CME Credit Course

2022 AIO | Large B-cell Lymphoma: What to do now and what’s coming next
Lymphoma
Non-CME Credit Course

2022 MCM | B-Cell Lymphomas: Updates and Future Directions
Lymphoma
Non-CME Credit Course

2022 NOSCM | DLBCL & Hodgkin’s Disease: Novel Approaches
Lymphoma
Non-CME Credit Course

2022 NOSCM | New Approaches for Follicular Lymphoma
Lymphoma
Non-CME Credit Course

2022 NOSCM | CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!
Lymphoma
Non-CME Credit Course

Follicular Lymphoma and CLL Updates 2023
Lymphoma
Non-CME Credit Course

2022 NOSCM | T-Cell NHL: Novel Approaches & Challenges
Lymphoma
Non-CME Credit Course

2022 CCC | Lymphoma: State of the Art
Lymphoma
Non-CME Credit Course

2022 UCT | Update on T-cell Lymphomas
Lymphoma
Non-CME Credit Course

2022 UCT | Modern Challenges and new options for B-cell NHL
Lymphoma
Non-CME Credit Course

2024 PRIMO | Update on Novel Therapies for NHL
Lymphoma
Non-CME Credit Course

2024 MCM | B-Cell NHL (Low-Grades)
Lymphoma
Non-CME Credit Course

2024 MLS Nashville | CLL/Lymphoma Updates in 2024
Lymphoma
Non-CME Credit Course

2024 NOSCM | What Is New for DLBCL and & Hodgkin’s Disease?
Lymphoma
Non-CME Credit Course

2024 NOSCM | Novel Advances in T-Cell NHL Therapies
Lymphoma
Non-CME Credit Course

2024 NOSCM | Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy
Lymphoma
Non-CME Credit Course

2024 NOSCM | CAR-T Cell Therapy in Lymphomas: 7-Years Later
Lymphoma
Non-CME Credit Course

2022 AIO | State of the Art in non-Hodgkin lymphoma
Lymphoma
Non-CME Credit Course

2024 MCM | T-Cell NHL- Novel Therapies
Lymphoma
Non-CME Credit Course

2024 MCM | B-Cell NHL (Aggressive) - Relapsed (CAR T versus Bispecifics?)
Lymphoma
Non-CME Credit Course
Contact Us



